cp wire

CP Wire Articles

FDA Accepts for Review Alkermes' and Biogen's NDA for Multiple Sclerosis Drug

Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) announced on 2/25/19 that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for... read more

Mon, 02/25/19 - 10:16 am
LivaNova Releases Safety and Technical Information for Valve-in-Valve Procedures on Its Perceval Platform

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced on 2/25/19 that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and... read more

Mon, 02/25/19 - 09:58 am
Imbrium Therapeutics and Mundipharma EDO Announce Orphan Drug Designation for Relapsed Refractory Biliary Tract Cancer Treatment



Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced on 2/21/19 that the U.S. Food and Drug Administration (FDA)... read more

Fri, 02/22/19 - 09:46 am
Outlook Therapeutics Files for $57 Million Offering

On 2/21/19 Outlook Therapeutics filed for a $57 million offering in part to support its treatment for wet AMD (age related macular degeneration). The filing did not specify the number of shares to... read more

Thu, 02/21/19 - 10:49 am
Microbiome Report for Week Ending 2/16/19

SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics... read more

Wed, 02/20/19 - 02:23 pm

Pages